Coronavirus Infections
Recent clinical, regulatory, research and industry developments relating to this disease.
Isolation of a more aggressive GVI-1 genotype strain HX of the avian infectious bronchitis virus.
Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic Viruses.
Microplastics dysregulate innate immunity in the SARS-CoV-2 infected lung.
COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responses.
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
SARS-CoV-2 vaccines in development.
Neurological associations of COVID-19.
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q4 2026.
Clinical MilestonesViewHide
- 2026-05-11ClinicalRandomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID (REVERSE-LC)Results expected Q4 2026
Research-associated treatments
Drugs and agents co-studied with this disease across the research literature — associative, not necessarily established treatments. Number shows shared papers.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Betacoronavirus63
- Pandemics49
- Coronavirus Infections40
- Pneumonia, Viral37
- Coronavirus8
- Disease Outbreaks6
- Immunity, Innate6
- Mental Health6
Leading journals6
- Frontiers in immunology13
- International journal of environmental research and public health8
- PloS one7
- European heart journal5
- Nature communications5
- Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin4
Leading researchers8
- Wang Y7
- Wang X5
- Zhang Y5
- Chen Y4
- Li Y4
- Wang J4
- Wang Z4
- Yang Y4
Affiliations (unnormalised)6
- School of Medicine9
- Icahn School of Medicine at Mount Sinai7
- School of Public Health7
- University of Oxford7
- Institut Pasteur5
- School of Nursing5
Disease biology
Key proteins & gene products studied in this disease. Number shows shared papers.
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Coronavirus infections are virus diseases caused by members of the Coronavirus genus. The grounding specifically includes human outbreaks such as SARS, MERS, and COVID-19, as well as animal diseases like transmissible enteritis of turkeys, feline infectious peritonitis, and transmissible gastroenteritis of swine.
They are caused by infection with coronaviruses, including SARS-CoV, MERS-CoV, and SARS-CoV-2 in humans. The grounding also indicates spillover from animal coronaviruses to humans and notes related coronaviruses in bats and pigs.
The literature grounding emphasizes viral virology, receptor usage, and virus replication. It also highlights host immune responses, including innate immunity, cytokines, interferon type I, antibodies, neutralizing antibodies, and the spike glycoprotein interacting with receptors such as ACE2.
The supplied grounding supports exposure to coronaviruses through transmission and spillover from animal reservoirs as a risk context. It also indicates that phylogenetic relatedness and receptor usage are relevant to emergence and spread, but does not provide specific individual risk factors.
The grounding supports prevention and control through vaccination, including COVID-19 vaccines. It also shows therapeutic study of drug therapy and immunomodulatory approaches such as hydroxychloroquine, azithromycin, tocilizumab, vitamin D, and quercetin, but does not support a single standard treatment regimen across coronavirus infections.
AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.